INSIGHTS ON CLINICAL TRIAL DESIGN
-
![patient-voice-mental-health-GettyImages-1975794314]( "Executing Concurrent Decentralized RCTs And RWE At Scale")
Executing Concurrent Decentralized RCTs And RWE At ScaleSee how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.
-
![Critical Inputs For Configuring An RTSM]( "Critical Inputs For Configuring An RTSM")
Critical Inputs For Configuring An RTSMUncover why clearly defined visit schedules and dispensing events are essential in RTSM design — and how resolving protocol ambiguity early prevents downstream complexity across systems and sites.
-
![Senior medical checkup patient and doctor-GettyImages-1938542779]( "Navigating The 7 Biggest Challenges In Rare Disease Clinical Trials")
Navigating The 7 Biggest Challenges In Rare Disease Clinical TrialsDiscover how partnering with specialized rare disease CROs allows drug sponsors to accelerate treatment development, navigate trial complexities, and ultimately improve patient outcomes.
-
![GettyImages-1309471798 respiratory]( "How Expert Medical Information Support Strengthened A Rare Respiratory Therapy Launch")
How Expert Medical Information Support Strengthened A Rare Respiratory Therapy LaunchEmbedded medical information expertise enabled compliant, real‑time scientific engagement with healthcare professionals at a high‑profile congress during a critical product launch.
-
Does 'The Belmont Report' Provide Guidance For Patient Stipends?12/5/2025
Consider implementing fair and flexible stipend models that account for individual burdens to enhance diversity, equity, and participation in clinical trials.
-
Beyond The Database: Reaching Real Patients In Real Communities5/14/2025
There’s fatigue around “database-only” recruitment tactics. This presentation spotlights how patient-centric, local engagement are outperforming traditional pipelines.
-
Planning For Clinical Trial Chaos8/28/2026
Clinical study management has fundamentally changed. This video explores why the traditional top-heavy approach must give way to more efficient, adaptable products.
-
Rare Disease Development: Navigating Small Populations And Complex Protocols5/22/2026
Learn how you can navigate the complexity of rare disease development with flexible trial design, integrated regulatory strategy, and data-driven execution built for small populations and global programs.
-
How A Small Biotech Partnered With Us To Navigate Trial Complexity With Confidence And Control7/30/2026
Early-phase trials often evolve rapidly. See how a flexible RTSM approach helped a biotech sponsor manage major protocol changes without disrupting study execution.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![microplate panel for diseases diagnosis GettyImages-1387090964]( "Bringing Endocrine And Metabolic Disease Treatments To Market")
Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.
-
![GettyImages-2213261066-patient-nurse-health-care]( "Flexible And Simplified Consent Management")
Learn about a unified ecosystem integrating eConsent, IRT, eCOA, and ePatient into a seamless workstream designed with a patient-centric approach.
-
![GettyImages-953449116 clinical trial oversight]( "Smarter Oversight, Earlier Action")
When risk-based oversight is reduced to a compliance checkbox, critical signals can be missed and escalate into systemic issues.
-
![GettyImages-2148023123-oncology-patient-appointment]( "Ready To Reach Proof Of Concept Faster?")
Proof-of-concept provides a critical bridge between Phase 1 and Phase 2 trials, making an experienced CRO partner vital to achieving optimal outcomes for early-phase clinical research.
-
![Website]( "Orchestrated Study Start-Up")
Learn how the IQVIA Investigator Site Portal reduces activation timelines and eliminates site frustrations by automating processes and providing complete oversight to study teams.
